Cowealth Medical Holding Co Ltd (4745) - Net Assets

Latest as of March 2026: NT$5.14 Billion TWD ≈ $161.95 Million USD

Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has net assets worth NT$5.14 Billion TWD (≈ $161.95 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$7.18 Billion ≈ $226.10 Million USD) and total liabilities (NT$2.04 Billion ≈ $64.16 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 4745 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$5.14 Billion
% of Total Assets 71.63%
Annual Growth Rate 14.9%
5-Year Change 43.45%
10-Year Change N/A
Growth Volatility 27.2

Cowealth Medical Holding Co Ltd - Net Assets Trend (2017–2025)

This chart illustrates how Cowealth Medical Holding Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Cowealth Medical Holding Co Ltd stock valuation.

Annual Net Assets for Cowealth Medical Holding Co Ltd (2017–2025)

The table below shows the annual net assets of Cowealth Medical Holding Co Ltd from 2017 to 2025. Also explore Cowealth Medical Holding Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 NT$5.06 Billion
≈ $159.31 Million		 -2.65%
2024-12-31 NT$5.19 Billion
≈ $163.65 Million		 +3.30%
2023-12-31 NT$5.03 Billion
≈ $158.42 Million		 -3.34%
2022-12-31 NT$5.20 Billion
≈ $163.89 Million		 +47.57%
2021-12-31 NT$3.53 Billion
≈ $111.06 Million		 +2.74%
2020-12-31 NT$3.43 Billion
≈ $108.10 Million		 +2.59%
2019-12-31 NT$3.34 Billion
≈ $105.38 Million		 +76.81%
2018-12-31 NT$1.89 Billion
≈ $59.60 Million		 +13.66%
2017-12-31 NT$1.66 Billion
≈ $52.44 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Cowealth Medical Holding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 59.6% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$282.08 Million 9.83%
Other Components NT$2.59 Billion 90.17%
Total Equity NT$2.87 Billion 100.00%

Cowealth Medical Holding Co Ltd Competitors by Market Cap

The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their market capitalization.

Company Market Cap
PPK Group Ltd
AU:PPK
 $24.42 Million
Catena Media plc
ST:CTM
 $24.42 Million
S2 Resources Ltd
AU:S2R
 $24.45 Million
Flap Kongre Toplanti Hizmetleri Otomotiv ve Turizm AS
IS:FLAP
 $24.46 Million
SABUY TECHNOLOGY
BK:SABUY-R
 $24.40 Million
Scandinavian Investment Group A/S
CO:SIG
 $24.39 Million
Local Bounti Corp
NYSE:LOCL
 $24.39 Million
Nara Mold & Die Co. Ltd
KQ:051490
 $24.39 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cowealth Medical Holding Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,798,820,000 to 2,870,165,000, a change of 71,345,000 (2.5%).
  • Net loss of 246,557,000 reduced equity.
  • Other factors increased equity by 317,902,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$-246.56 Million -8.59%
Other Changes NT$317.90 Million +11.08%
Total Change NT$- 2.55%

Book Value vs Market Value Analysis

This analysis compares Cowealth Medical Holding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.32x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.56x to 0.32x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 NT$20.81 NT$11.70 x
2018-12-31 NT$23.63 NT$11.70 x
2019-12-31 NT$31.57 NT$11.70 x
2020-12-31 NT$32.84 NT$11.70 x
2021-12-31 NT$33.13 NT$11.70 x
2022-12-31 NT$36.59 NT$11.70 x
2023-12-31 NT$35.09 NT$11.70 x
2024-12-31 NT$36.14 NT$11.70 x
2025-12-31 NT$37.06 NT$11.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cowealth Medical Holding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -8.59%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -8.34%
  • • Asset Turnover: 0.42x
  • • Equity Multiplier: 2.45x
  • Recent ROE (-8.59%) is below the historical average (4.96%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 10.43% 5.72% 0.84x 2.18x NT$7.14 Million
2018 15.64% 7.34% 0.95x 2.24x NT$103.14 Million
2019 11.44% 6.00% 0.86x 2.21x NT$35.27 Million
2020 4.89% 2.63% 0.88x 2.11x NT$-130.12 Million
2021 5.43% 2.71% 0.95x 2.10x NT$-117.32 Million
2022 3.32% 1.67% 0.78x 2.54x NT$-189.42 Million
2023 2.05% 1.16% 0.73x 2.44x NT$-216.18 Million
2024 0.02% 0.02% 0.60x 2.49x NT$-279.25 Million
2025 -8.59% -8.34% 0.42x 2.45x NT$-533.57 Million

Industry Comparison

This section compares Cowealth Medical Holding Co Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $1,777,755,200
  • Average return on equity (ROE) among peers: 5.03%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Cowealth Medical Holding Co Ltd (4745) NT$5.14 Billion 10.43% 0.40x $24.41 Million
Hi-Clearance (1788) $3.00 Billion 11.98% 0.65x $179.54 Million
Radiant Innovation (3373) $793.80 Million -7.61% 0.09x $23.93 Million
Wellell Inc (4106) $2.06 Billion 4.95% 0.52x $77.57 Million
Rossmax International Ltd (4121) $1.34 Billion 1.24% 0.71x $32.72 Million
United Orthopedic (4129) $3.59 Billion 10.69% 0.79x $250.36 Million
Dynamic Medical Technologies (4138) $1.46 Billion 7.93% 0.46x $67.81 Million
Ok Biotech Co Ltd (4155) $1.74 Billion 7.46% 0.46x $66.03 Million
Bioptik Technology (4161) $887.42 Million -3.80% 0.76x $41.93 Million
AViTA Corporation (4735) $838.11 Million 6.91% 0.42x $43.25 Million
TAIDOC TECHNOLOGY CORP (4736) $2.05 Billion 10.57% 0.48x $385.16 Million

About Cowealth Medical Holding Co Ltd

TWO:4745 Taiwan Medical Devices
Market Cap
$24.41 Million
NT$774.78 Million TWD
Market Cap Rank
#24548 Global
#1525 in Taiwan
Share Price
NT$11.70
Change (1 day)
+0.43%
52-Week Range
NT$10.40 - NT$26.85
All Time High
NT$42.03
Categories
Companies in Taiwan Medical Devices
About

Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more